Carveol

Carveol
Identifiers
CAS number 99-48-9 N
PubChem 7438, 2724032 (5R), 11084068 (5S), 330573 (1R,5R), 443178 (1R,5S)
ChemSpider 7160 N, 2006207 (5R) Y, 9259214 (5S) Y, 292842 (1R,5R) Y, 391450 (1R,5S) Y
EC number 202-757-4
KEGG C11395 N
MeSH Carveol
ChEBI CHEBI:23046 N
RTECS number OS8400000
Beilstein Reference 1861032
3DMet B04241
Jmol-3D images Image 1
Image 2
Properties
Molecular formula C10H16O
Molar mass 152.23 g mol−1
Exact mass 152.120115134 g mol-1
Density 0.958 g cm-3
Boiling point

226-227 °C, 499-500 K, 439-441 °F

Hazards
EU classification Xi
R-phrases R36/37/38
S-phrases S26 S37/39
NFPA 704
1
1
0
Flash point 98 °C (208 °F)
 N (verify) (what is: Y/N?)
Except where noted otherwise, data are given for materials in their standard state (at 25 °C, 100 kPa)
Infobox references

Carveol is a natural unsaturated, monocyclic monoterpenoid alcohol that is a constituent of spearmint essential oil in the form of cis-(−)-carveol. It is a colorless fluid soluble in water and oils, but insoluble in water and has an odor and flavor that resemble those of spearmint and caraway. Consequently, it is used as a fragrance in cosmetics and as a flavor additive in the food industry.

It has been found to exhibit chemoprevention of mammary carcinogenesis (prevents breast cancer).[2]

An alpha-trans-dihydroxy derivative ((1R,2R,6S)-3-methyl-6-(prop-1-en-2-yl)cyclohex-3-ene-1,2-diol) possesses potent antiparkinsonian activity in animal models.[3]

References

  1. ^ "Carveol". Chemical Entities of Biological Interest. UK: European Bioinformatics Institute. https://www.ebi.ac.uk/chebi/searchId.do?chebiId=23046. 
  2. ^ Crowell, PL; Kennan, WS; Haag, JD; Ahmad, S; Vedejs, E; Gould, MN (1992). "Chemoprevention of mammary carcinogenesis by hydroxylated derivatives of d-limonene". Carcinogenesis 13 (7): 1261–4. doi:10.1093/carcin/13.7.1261. PMID 1638695. 
  3. ^ Ardashov, Oleg V.; Pavlova, Alla V.; Il’Ina, Irina V.; Morozova, Ekaterina A.; Korchagina, Dina V.; Karpova, Elena V.; Volcho, Konstantin P.; Tolstikova, Tat’Yana G. et al. (2011). "Highly Potent Activity of (1R,2R,6S)-3-Methyl-6-(prop-1-en-2-yl)cyclohex-3-ene-1,2-diol in Animal Models of Parkinson's Disease". Journal of Medicinal Chemistry 54 (11): 3866–3874. doi:10.1021/jm2001579. PMID 21534547.